Safety and Efficacy of the Ultimaster Stent

Active, not recruitingOBSERVATIONAL

Enrollment

204

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

February 13, 2025

Study Completion Date

February 13, 2025

Conditions

Coronary Artery DiseaseDrug-eluting Stents

Interventions

DEVICE

ultimaster

Subjects who received Ultimaster stent will be included.

Trial Locations (1)

Yongin Severance Hospital, Yongin

All Listed Sponsors

collaborator

Terumo Corporation

INDUSTRY

lead

Yonsei University

OTHER